Treace Medical Concepts Inc (TMCI) PT Raised to $16 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St futures up as oil slips; telecoms pressured by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- UBS flags level in gold prices where dip buyers will likely emerge
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- Investors need sustained Fed cuts to move cash off sidelines: BofA's Hartnett
Tweet
Share
E-mailGet Alerts TMCI Hot Sheet
Price: $3.88 --0%
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 28
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 28
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Treace Medical Concepts Inc (NASDAQ: TMCI) to $16.00 (from $12.00) while maintaining a Buy rating.
You May Also Be Interested In
- LG Electronics (066570:KS) PT Lowered to KRW320,000 at Citi
- Kinsale Capital (KNSL) PT Raised to $375 at JPMorgan
- Cloudflare Inc. (NET) PT Raised to $430 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
